Answers are grounded in this paper and cite their sources.
Commentary discusses therapeutic promise and ethical barriers in stem cell cancer treatments.
Stem cell-based cancer therapies offer novel mechanisms for tumour targeting, immune modulation and tissue repair, with applications from haematopoietic to induced pluripotent stem cells. While showing strong therapeutic promise, their clinical translation is hindered by ethical, regulatory and economic barriers. Coordinated global action is essential to unlock their full potential in oncology.
No takes yet. Share an insight, caveat, or question.
Thin et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: